Tag: Cancer: Pancreatic

Positive associations seen for celiac disease, SLE, T1D with pancreatic, esophageal, colon, liver, and hepatobiliary cancers

Better posttreatment pathology and similar overall survival seen for stereotactic ablative radiotherapy group despite more advanced disease

Increase seen across age groups, while incidence of colorectal adenocarcinoma increased most in those aged 15 to 34 years

Lower odds of receiving key components of quality care seen for those with high overall social vulnerability index

In recent study, PAC-MANN identified pancreatic ductal adenocarcinoma samples with 98 percent specificity and 73 percent sensitivity across all stages

Primary end point not met, but small subset of advanced pancreatic ductal adenocarcinoma patients showed durable responses

Increasing incidence mainly due to increased detection of smaller, early-stage endocrine cancer, not adenocarcinoma

Palliative care consultations have no significant impact on the likelihood of documented treatment

Most people erroneously think pancreatic cancer occurs only in older people and that they cannot alter risk